MP, L., MS, G., M, E., J, G., & J, S. (2022). Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.
Citación estilo ChicagoMP, Lennol, García-Ayllón MS, Esteban M, García-Arriaza J, y Sáez-Valero J. Serum Angiotensin-converting Enzyme 2 As a Potential Biomarker for SARS-CoV-2 Infection and Vaccine Efficacy. 2022.
Cita MLAMP, Lennol, et al. Serum Angiotensin-converting Enzyme 2 As a Potential Biomarker for SARS-CoV-2 Infection and Vaccine Efficacy. 2022.
Precaución: Estas citas no son 100% exactas.